GPNMB and CCL18 showed a peak in expression in the rim of chronic active MS lesions, compared to the rim of inactive MS lesions, with a fold change of 8.0 and 6.8, respectively (Figure 2). Here, CCL18 is linked to myeloid sarcoma.